Citadel Advisors’s Allied Healthcare Products AHPI Stock Holding History
Bought
Maintained
Sold
Other funds holding AHPI
SSA
SFI
VF
HIS
Citadel Advisors's AHPI Position: Q3 2021 in Review
Citadel Advisors sold out of Allied Healthcare Products (AHPI) in Q3 2021, closing a stake of 19,263 shares — an estimated $80K sold.
Citadel Advisors first reported a position in AHPI in Q4 2014 and held it in 16 quarters. The position peaked at $210K in Q1 2021. 13 funds tracked by Wall St. Rank hold AHPI as of Q3 2021.
- Citadel Advisors reported no remaining Allied Healthcare Products position as of Q3 2021 after selling out during the quarter.
- Citadel Advisors sold 19,263 Allied Healthcare Products shares in Q3 2021, an estimated $80K.
- Citadel Advisors first reported a position in Allied Healthcare Products in Q4 2014 and held it in 16 quarters.
- Citadel Advisors's Allied Healthcare Products position peaked at $210K in Q1 2021.
- 13 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2021.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.